VMS063 is a novel, potential first- and best-in-class monoclonal antibody investigational candidate discovered by Invivyd The U.S. is experiencing a record-breaking number of measles cases in 2026, ...

You may not have heard of human metapneumovirus, or HMPV, but every year this virus sends millions of people to the hospital. In children under five, it causes an estimated 14 million serious lung ...

Trials are beginning on several drugs that have shown promise in preliminary studies against the virus that is causing the current outbreak. A health worker in the town of Mongbwalu, Democratic ...

Treatment with bepirovirsen, an antisense oligonucleotide targeting hepatitis B virus (HBV) transcripts, has the potential to result in a functional cure, defined by at least 24 weeks of a sustained ...

Women on CagriSema lost 25% of their body weight in a post hoc trial analysis, while 79.6% of users had digestive side effects. The drug is not approved. Ice Water, Math Quizzes, and Shocks: The 1948 ...

Share on Pinterest Clinical trials for targeted new Ebola vaccine and treatments have now begun. PixelCatchers/Getty Images On July 2, 2026, the World Health Organization (WHO) and the Institut ...

T cells are some of the immune system’s most important fighters. They can stop tumor growth and fight off severe infections. Scientists at La Jolla Institute for Immunology (LJI) have now reported a ...

Cases of human metapneumovirus, or HMPV, are hitting certain states, including California and New Jersey. HMPV can cause upper and lower respiratory disease, and currently there is no vaccine to ...